Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Core Laboratories (CLB) Invested Capital (2022 - 2025)

Core Laboratories' Invested Capital history spans 4 years, with the latest figure at $272.2 million for Q4 2025.

  • For Q4 2025, Invested Capital rose 10.4% year-over-year to $272.2 million; the TTM value through Dec 2025 reached $272.2 million, up 10.4%, while the annual FY2025 figure was $272.2 million, 10.4% up from the prior year.
  • Invested Capital reached $272.2 million in Q4 2025 per CLB's latest filing, roughly flat from $271.3 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $272.2 million in Q4 2025 to a low of $173.8 million in Q2 2022.
  • Average Invested Capital over 4 years is $231.4 million, with a median of $237.4 million recorded in 2024.
  • Peak YoY movement for Invested Capital: increased 26.38% in 2023, then increased 5.82% in 2025.
  • A 4-year view of Invested Capital shows it stood at $183.5 million in 2022, then grew by 22.26% to $224.4 million in 2023, then rose by 9.89% to $246.6 million in 2024, then increased by 10.4% to $272.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLB's Invested Capital are $272.2 million (Q4 2025), $271.3 million (Q3 2025), and $267.3 million (Q2 2025).